BRETARIS GENUAIR

This brand name is authorized in Australia, Austria, Croatia, Estonia, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain.

Active ingredients

The drug BRETARIS GENUAIR contains one active pharmaceutical ingredient (API):

1
UNII UQW7UF9N91 - ACLIDINIUM BROMIDE
 

Aclidinium is a competitive, selective muscarinic receptor antagonist (also known as an anticholinergic), with a longer residence time at the M3 receptors than the M2 receptors. M3 receptors mediate contraction of airway smooth muscle. Inhaled aclidinium acts locally in the lungs to antagonise M3 receptors of airway smooth muscle and induce bronchodilation.

 
Read more about Aclidinium

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BRETARIS GENUAIR Inhalation powder MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03BB05 R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10124W
EE Ravimiamet 1590094, 1590106, 1590117
ES Centro de información online de medicamentos de la AEMPS 12781002
LT Valstybinė vaistų kontrolės tarnyba 1067100, 1067101, 1067102
NL Z-Index G-Standaard, PRK 104787
NZ Medicines and Medical Devices Safety Authority 16607
PL Rejestru Produktów Leczniczych 100284388
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W69358001, W69358002, W69358003

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.